FcRn as a Transporter for Nasal Delivery of Biologics: A Systematic Review

FcRn as a Transporter for Nasal Delivery of Biologics: A Systematic Review

FcRn plays a major role in regulating immune homeostasis, but it is also able to transport biologics across cellular barriers. The question of whether FcRn could be an efficient transporter of biologics across the nasal epithelial barrier is of particular interest, as it would allow a less invasive...

Full description

Bibliographic Details
Main Authors:	Maxime Fieux, Sandra Le Quellec, Sophie Bartier, André Coste, Bruno Louis, Caroline Giroudon, Mikail Nourredine, Emilie Bequignon
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Series:	International Journal of Molecular Sciences
Subjects:	neonatal Fc receptor monoclonal antibody immunoglobulin G Fc-fusion protein transcytosis nasal route
Online Access:	https://www.mdpi.com/1422-0067/22/12/6475

Similar Items

Monoclonal Antibody Engineering and Design to Modulate FcRn Activities: A Comprehensive Review
by: Yanis Ramdani, et al.
Published: (2022-08-01)

In Translation: FcRn across the Therapeutic Spectrum
by: Timothy Qi, et al.
Published: (2021-03-01)

FcRN receptor antagonists in the management of myasthenia gravis
by: Vinaya Bhandari, et al.
Published: (2023-08-01)

Modifying antibody-FcRn interactions to increase the transport of antibodies through the blood-brain barrier
by: Jason Tien, et al.
Published: (2023-12-01)

Identification of Four Mouse FcRn Splice Variants and FcRn-Specific Vesicles
by: George Haddad, et al.
Published: (2024-03-01)

Megalin Orchestrates FcRn Endocytosis and Trafficking
by: Eileen Dahlke, et al.
Published: (2022-12-01)

Harnessing Fc/FcRn Affinity Data from Patents with Different Machine Learning Methods
by: Christophe Dumet, et al.
Published: (2023-03-01)

The Dual Targeting of FcRn and FcγRs via Monomeric Fc Fragments Results in Strong Inhibition of IgG-Dependent Autoimmune Pathologies
by: Céline Monnet, et al.
Published: (2021-08-01)

The influence of antibody engineering on Fc conformation and Fc receptor binding properties: Analysis of FcRn-binding engineered antibodies and an Fc fusion protein
by: Takuo Suzuki, et al.
Published: (2021-01-01)

Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells in vitro
by: Omar S. Qureshi, et al.
Published: (2024-12-01)

Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy
by: Christopher R. Wilcox, et al.
Published: (2017-10-01)

Roles of FcRn in Antigen-Presenting Cells during Autoimmunity and a Clinical Evaluation of Efgartigimod as an FcRn Blocker
by: Yihan Zhou, et al.
Published: (2023-06-01)

FcRn Expression in Wildtype Mice, Transgenic Mice, and in Human Tissues
by: Tommy Li, et al.
Published: (2018-10-01)

The role of FcRn in antigen presentation
by: Kristi eBaker, et al.
Published: (2014-08-01)

Clinical Significance of Serum Albumin and Implications of FcRn Inhibitor Treatment in IgG-Mediated Autoimmune Disorders
by: E. Sally Ward, et al.
Published: (2022-06-01)

FcRn Overexpression Expands Diversity of the Humoral Immune Response in bFcRn Transgenic Mice
by: Bence Szikora, et al.
Published: (2020-08-01)

Selection of IgG variants with increased FcRn binding using random and directed mutagenesis: impact on effector functions
by: Céline eMonnet, et al.
Published: (2015-02-01)

Selection of bispecific antibodies with optimal developability using FcRn‑pH‑HPLC as an optimized FcRn affinity chromatography method
by: Thomas Müller, et al.
Published: (2023-12-01)

Fully human monoclonal antibody inhibitors of the neonatal Fc receptor (FcRn) reduce circulating IgG in nonhuman primates
by: Andrew E Nixon, et al.
Published: (2015-04-01)

Inhibitory Fc-Gamma IIb Receptor Signaling Induced by Multivalent IgG-Fc Is Dependent on Sialylation
by: Christopher Beneduce, et al.
Published: (2023-08-01)

Production and characterization of monoclonal antibodies anti fragment Fc of bovine IgG
by: Tânia Regina Penha, et al.
Published: (2010-02-01)

Trafficking analyses of FcRn and IgG ligand in the post-Brambell era
by: E. Sally eWard, et al.
Published: (2015-07-01)

FcRn Expression in Endometrial Cancer and Its Association with Clinicopathologic Features
by: Dae Hyun Song, et al.
Published: (2023-12-01)

The Neonatal Fc Receptor (FcRn): A Misnomer?
by: Michal Pyzik, et al.
Published: (2019-07-01)

Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRn in vitro and in vivo
by: Simone Mester, et al.
Published: (2021-01-01)

Human FcRn Is a Two-in-One Attachment-Uncoating Receptor for Echovirus 18
by: Xiangpeng Chen, et al.
Published: (2022-08-01)

Study on FcγRn Electrochemical Receptor Sensor and Its Kinetics
by: Dandan Peng, et al.
Published: (2020-07-01)

Human FcRn can mediate the transport across intestinal mucosal barrier and prolong the half-life of rabbit IgG in vivo
by: Guangchang Pang, et al.
Published: (2015-06-01)

Association of IgG1 Antibody Clearance with FcγRIIA Polymorphism and Platelet Count in Infliximab-Treated Patients
by: Gilles Thibault, et al.
Published: (2021-06-01)

Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia
by: Trang T. Vu, et al.
Published: (2024-01-01)

Human FcRn Tissue Expression Profile and Half-Life in PBMCs
by: Yao-Yun Fan, et al.
Published: (2019-08-01)

The contribution of cell surface FcRn in monoclonal antibody serum uptake from the intestine in suckling rat pups
by: Philip R Cooper, et al.
Published: (2014-10-01)

FcRn Antagonism Leads to a Decrease of Desmoglein-Specific B Cells: Secondary Analysis of a Phase 2 Study of Efgartigimod in Pemphigus Vulgaris and Pemphigus Foliaceus
by: Maud Maho-Vaillant, et al.
Published: (2022-05-01)

Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary names
by: Ian Wilkinson, et al.
Published: (2022-12-01)

Lack of FcRn Impairs Natural Killer Cell Development and Functions in the Tumor Microenvironment
by: Diana Cadena Castaneda, et al.
Published: (2018-09-01)

Pharmacokinetics of novel Fc-engineered monoclonal and multispecific antibodies in cynomolgus monkeys and humanized FcRn transgenic mouse models
by: Delphine Valente, et al.
Published: (2020-01-01)

Engineering of Fc Fragments with Optimized Physicochemical Properties Implying Improvement of Clinical Potentials for Fc-Based Therapeutics
by: Chunpeng Yang, et al.
Published: (2018-01-01)

Tissues Expression, Polymorphisms Identification of FcRn Gene and Its Relationship with Serum Classical Swine Fever Virus Antibody Level in Pigs
by: Liu Yang, et al.
Published: (2012-08-01)

Fc-Effector-Independent in vivo Activity of a Potent Influenza B Neuraminidase Broadly Neutralizing Antibody
by: Ahmed M. Khalil, et al.
Published: (2023-07-01)

Studies of Fc receptors mediating IgG transport
by: Simister, N
Published: (1985)